Cureatr Inc.

Cureatr Inc. , located in the US, specializes in innovative medication management services that enhance patient outcomes through effective care transitions and pharmacist integration into healthcare teams. Cureatr Inc. was founded in 2011 in New York, US, focusing on medication management solutions.

The company has raised a total of USD 11. 1 mn in funding, with the most recent deal occurring on February 26, 2021. The firm has executed 6 deals in its history, aiming to improve the healthcare delivery system through its services. Alex Khomenko is the founder, while Richard Resnick serves as the CEO.

Cureatr specializes in comprehensive medication management services designed to support patients through a patient-first approach. Their core offerings include the integration of clinical pharmacists into care teams, providing longitudinal medication management and facilitating timely patient engagement. This model aims to mitigate the challenges associated with medication reconciliation post-discharge, serving hospitals, health systems, and payers across the United States. By leveraging advanced access to clinical data and prescribing databases, Cureatr's services enhance patient care while promoting better health outcomes.

Their clinical pharmacists act as a critical link in the healthcare continuum, assisting patients, caregivers, and physicians to ensure medication adherence and effective care transitions. Cureatr operates primarily on a B2B model, generating revenue through partnerships and service agreements with healthcare systems and payers. The company’s revenue structure includes fees associated with its medication management services, which may involve subscription-based pricing for healthcare organizations utilizing their platform. These arrangements typically focus on improving metrics related to Medicare Stars and HEDIS, reflecting the quality of care provided to patients.

Additionally, Cureatr's offerings may include customized solutions to address specific client needs, allowing for variable pricing based on the scope of services rendered. In February 2021, Cureatr Inc. raised USD 11. 1 mn in venture funding, part of a larger USD 13.

2 mn equity funding round. The company plans to utilize this funding to enhance its existing services and develop new products that improve medication management. Cureatr is focused on expanding its market reach into additional healthcare systems across the US, with specific plans to enter new geographic regions by 2023, aiming to bolster their partnerships and increase patient engagement.